All Insights
Showing 25 - 36 of 318
Life Sciences and Healthcare
EU regulatory activity is driving comprehensive reforms for pharma in 2025
The European Union's regulatory framework for the pharmaceutical sector is undergoing significant transformations
Commercial
New EU packaging and waste regulation comes into force to promote sustainability
Effective implementation of this advance for the circular economy now depends on national legislation by Member States
Regulatory and compliance
Court of Appeal rules on duty to clarify tender submissions with bidders in UK public procurement
Decision explains when contracting authorities must clarify incomplete or ambiguous information in tender submissions
Life Sciences and Healthcare
The fight against counterfeit medicines in Italy
The Italian legislative decree implementing Regulation (EU) 2016/161 enters into force
Life Sciences and Healthcare
The Future of Cannabis in Germany: What to Expect After the 2025 Elections
The German cannabis industry is transforming rapidly. The introduction of the Cannabis Act (CanG) in April 2024 brought significant changes
Regulatory and compliance
New NPPS sets out 'value for money' message for UK public procurement
Government wants public bodies to use procurement to drive growth, social and economic value, and commercial capability
Life Sciences and Healthcare
Genetic resources, IP and benefits sharing: what changes are ahead internationally?
The WIPO has set out disclosure rules for patent applications as the UN pushes for sharing digital sequence information
Life Sciences and Healthcare
Streamlined reimbursement law looks to boost medicine access in Poland
What can Poland's pharmaceutical industry expect from further reforms due in the second quarter of this year?
IT and data
What will be the impact of the European Health Data Space Regulation on life sciences companies?
The EHDS is in its final stages, creating a common data space for the first time
Life Sciences and Healthcare
What governance challenges does the UK engineering biology sector face?
The Regulatory Horizons Council's latest report outlines recommendations on ensuring effective governance of engineering biology products
Life Sciences and Healthcare
AI literacy becomes mandatory for life sciences across the EU
The pharma and medtech sectors have a strategic window to implement AI literacy ahead of an August enforcement deadline
Life Sciences and Healthcare
EU General Court's invalidity finding on 3D shape mark highlights med devices' trade mark woes
Ruling that shape was functional is consistent with trade mark law's aim to prevent monopolies on technical solutions
